Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Indo US Bio-Tech's 3-Year RORE % for the quarter that ended in Mar. 2026 was 6.47%.
The industry rank for Indo US Bio-Tech's 3-Year RORE % or its related term are showing as below:
NSE:INDOUS's 3-Year RORE % is ranked worse than 52.05% of 244
companies
in the Agriculture industry
Industry Median: 7.235
vs NSE:INDOUS: 6.47
Indo US Bio-Tech (NSE:INDOUS) 3-Year RORE % Explanation
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Indo US Bio-Tech 3-Year RORE % Related Terms
Indo US Bio-Tech 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Indo US Bio-Tech's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDOUS vs CTVA, CF, MOS: 3-Year RORE % Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech 3-Year RORE % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Indo US Bio-Tech (NSE:INDOUS) has a 3-Year RORE % of 6.47 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Indo US Bio-Tech and its competitors. According to the industry distribution chart, Indo US Bio-Tech ranks #127 out of 244 companies in the Agriculture industry, placing it in the top 52%.
Is Indo US Bio-Tech's 3-Year RORE % too high?
Indo US Bio-Tech's current 3-Year RORE % is 6.47. The Agriculture industry median 3-Year RORE % is 7.24. Indo US Bio-Tech's value of 6.47 is 10.6% below this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #127 out of 244 companies in the Agriculture industry, which is below the industry midpoint. Overall, Indo US Bio-Tech has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's 3-Year RORE % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #127 out of 244 companies for 3-Year RORE %. This places Indo US Bio-Tech in the lower half of its industry. The industry median 3-Year RORE % is 7.24. Indo US Bio-Tech's value of 6.47 is 10.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for an Agriculture company?
The median 3-Year RORE % among Agriculture companies is 7.24, based on 244 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current 3-Year RORE % of 6.47 is 10.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median 3-Year RORE % is 7.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current 3-Year RORE % is 6.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹313.37, compared to a current price of ₹84.98 — trading 72.9% below its estimated fair value. The current 3-Year RORE % is 6.47 and 10.6% below the Agriculture industry median of 7.24. Indo US Bio-Tech's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current 3-Year RORE % is 6.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹84.98 is trading 72.9% below its estimated GF Value™ of ₹313.37.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
3-Year RORE %: 6.47
GF Value™: ₹313.37 vs. price of ₹84.98 (72.9% below fair value)
Industry Position: 10.6% below the Agriculture median (#127 of 244)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
64GF Score
Get the complete analysis for NSE:INDOUS
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
